Compare NVRI & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVRI | OMCL |
|---|---|---|
| Founded | 1853 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Computer Manufacturing |
| Sector | Miscellaneous | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 1994 | 2000 |
| Metric | NVRI | OMCL |
|---|---|---|
| Price | $19.63 | $43.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $55.83 |
| AVG Volume (30 Days) | ★ 782.9K | 588.7K |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $2,240,358,000.00 | $787,309,000.00 |
| Revenue This Year | $3.87 | $6.77 |
| Revenue Next Year | $3.70 | $5.22 |
| P/E Ratio | ★ N/A | $174.56 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $7.35 | $26.85 |
| 52 Week High | $19.99 | $51.84 |
| Indicator | NVRI | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 56.06 | 62.50 |
| Support Level | $18.90 | $43.34 |
| Resistance Level | $19.71 | $44.31 |
| Average True Range (ATR) | 0.53 | 2.03 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 81.47 | 67.14 |
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.